CA
NZ
UK
AU
IND
US
Silver Lake Technology Investors IV, L.P. and affiliated reporting persons filed a Form 4 with the SEC on September 21, 2026, disclosing sales and a Class B-to-Class C conversion of Dell Technologies Inc. (NYSE:DELL) Class C Common Stock transacted on September 17, 2026.
Silver Lake Technology Investors V, L.P. and related reporting persons filed a Form 4 with the SEC on September 21, 2026, disclosing the sale of Class C Common Stock of Dell Technologies Inc. (NYSE:DELL) and a related Class B-to-Class C conversion on September 17, …
Hershey Trust Co, acting as trustee for Milton Hershey School, filed a Form 4 on September 21, 2026, disclosing the sale of Hershey Co common stock across nine transactions on September 17 and 18, 2026, under a Rule 10b5-1 plan.
James Monroe III, a Director and 10% Owner of Globalstar, Inc. (NASDAQ:GSAT), filed a Form 4 on September 21, 2026, disclosing a purchase of 361,600 shares of Voting Common Stock on September 18, 2026.
Artur Bergman, Chief Technology Officer and Director of Fastly, Inc. (NASDAQ:FSLY), filed a Form 4 on September 21, 2026, reporting the sale of 2,200 shares of Class A Common Stock on September 17, 2026.
Jeffrey Ford, Principal Accounting Officer of Fastly, Inc. (NASDAQ:FSLY), filed a Form 4 on September 21, 2026, disclosing the sale of 45,832 shares of Class A Common Stock on September 17, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.
Scott R. Lovett, President, Go to Market at Fastly, Inc. (NASDAQ:FSLY), filed a Form 4 on September 21, 2026, disclosing the sale of 41,815 shares of Class A Common Stock on September 17, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.
Director John Michael DiMaio filed a Form 4 with the SEC on September 21, 2026, disclosing two open-market purchases of Spectral AI, Inc. common stock on September 18 and September 21, 2026.
Tricia D. Smith, Global CEO of the Anthropologie Group at Urban Outfitters Inc (NASDAQ:URBN), filed a Form 4 on September 21, 2026, reporting the sale of 3,500 common shares on September 18, 2026.
Dennis Phillip Andrew, Chief Medical Officer of NovaBridge Biosciences, filed a Form 4 on September 21, 2026, disclosing the vesting of restricted share units and a subsequent sale of ordinary shares on September 17 and 18, 2026.
Please wait processing your request...